QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates

This publication has 15 references indexed in Scilit:

• Are gender differences in QTc present at birth?
  The American Journal of Cardiology, 1995
• QT dispersion and components of the QT interval in ischaemia and infarction.
  Heart, 1995
• Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome.
  Circulation, 1994
• Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine
  The American Journal of Cardiology, 1994
• Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
  JAMA, 1993
• QT interval prolongation and cardiac arrest during antibiotic therapy with spiramycin in a newborn infant
  American Heart Journal, 1993
• Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol
  Clinical Pharmacology & Therapeutics, 1992
• Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications.
  Circulation, 1991
• Erythromycin-induced long QT syndrome: Concordance with quinidine and underlying cellular electrophysiologic mechanism
  The American Journal of Medicine, 1990
• QT prolongation and recurrent “torsades de pointes” during erythromycin lactobionate infusion
  The American Journal of Cardiology, 1986